These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 22529186)
1. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
2. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Le H; Zeng F; Xu L; Liu X; Huang Y Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862 [TBL] [Abstract][Full Text] [Related]
3. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy. Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005 [TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma. Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762 [TBL] [Abstract][Full Text] [Related]
8. CD133 mRNA expression and microsatellite instability in colorectal carcinoma. Huh JW; Park YS; Lee JH; Kim HR; Shin MG; Kim YJ J Surg Oncol; 2010 Dec; 102(7):765-70. PubMed ID: 20872808 [TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data. Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019 [TBL] [Abstract][Full Text] [Related]
11. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699 [TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating CD133(+) cells in patients with gastric cancer. Xia P; Song CL; Liu JF; Wang D; Xu XY Cell Prolif; 2015 Jun; 48(3):311-7. PubMed ID: 25727099 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. Xi HQ; Zhao P J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427 [TBL] [Abstract][Full Text] [Related]
17. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
18. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance. Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447 [TBL] [Abstract][Full Text] [Related]
20. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes. Roudi R; Korourian A; Shariftabrizi A; Madjd Z Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]